Sangamo Therapeutics Reports Second Quarter 2017 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. PLTR
6. JNJ
7. LDOS
8. HUM
9. CSCO
10. KTOS

Go back to Sangamo Therapeutics Reports Second Quarter 2017 Financial Results

Sangamo Biosciences (SGMO) Reports Q2 Loss of $0.17/Share

August 9, 2017 4:08 PM EDT

Sangamo Biosciences (NASDAQ: SGMO) reported Q2 EPS of ($0.17), versus ($0.38) reported last year. Revenue for the quarter came in at $8.3 million, versus $3.7 million reported last year.

GUIDANCE:

Sangamo Biosciences sees FY2017 revenue of $30-40 million, versus the consensus of $31.2 million.

For... More